BioUtah News
-
Multi-Center Liquid Embolic Study Concludes
Completion of Trial is a Sign of Things to Come for Novel Embolic Agent
-
BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay
FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global…
-
BioHive Women in STEM Event recap
BioHive continued its celebration of “STEM September” with the Women in STEM Mingle in downtown Salt Lake City…
-
2022 Biosphere Magazine Now Available
Each year, BioUtah publishes a special Utah life sciences magazine, Biosphere, released with the September issue of Utah Business…
-
Excess Equipment Sale for BioUtah Members
Excess Equipment Sale for BioUtah Members
-
FDA Clears Xenocor’s Saberscope, the World’s First Single-use 5mm Laparoscope with Auto-Focus
FDA Clears World’s First Single-use 5mm Laparoscope with Auto-Focus
-
Merit Medical Launches the TEMNO Elite™ Soft Tissue Biopsy System
Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety
-
AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy
The European Commission’s approval of a novel gene therapy for severe hemophilia A has paved the way for…
-
Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Business Highlights
Dynatronics reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an…
-
Recruitment for Non-Invasive Parkinson’s Pivotal Study Slated for December
Non-invasive Parkinson’s therapeutic device moves one step closer to FDA clearance, with important potential non-motor and motor improvements…
-
nView s1 reaches its 100th surgery
The nView s1 has just surpassed its landmark 100th clinical case with the help of 22 surgeons at…
-
EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL
Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
